Objective
STEM-TECH has been designed to investigate the commercial opportunity for exploiting our patented stem cell marker technology in the life sciences market. This proprietary technology will meet the need for new enabling technologies that unlock the potential of stem cell detection in academic, industrial and clinical research and practice.
THE OPPORTUNITY
The stem cell market is a relatively immature market with an estimated size of around EUR 1 billion in 2011. It is expected that the market for stem cell technologies will increase substantially, mainly because leading biopharmaceutical companies are showing considerable interest in this area. Next to the pharma industry, major suppliers and small companies are now developing a wide range of stem cell approaches, which reflects the interest in this emerging area. Companies like Invitrogen provide reagents and services for stem cell research.
THE PROJECT
In STEM-TECH the central aim is to commercialise a (cancer) stem cell detection technology that can be used in intestinal, skin, breast and brain (cancer) stem cell research for (not exhaustive):
- Fundamental and applied research purposes, e.g. the study of stem cell behaviour or signaling in and ex vivo;
- The development of clinical detection methods (diagnostics) for determining disease status and metastasis;
- The development of treatments that are specifically targeted at cancer stem cells.
THE FINAL GOAL
In a 12 month project, the skilled team of STEM-TECH will analyse the business potential of the proprietary stem cell marker technology. Within this project we will validate the technology to increase value, conduct a detailed market research, file and define the IP stratetgy and develop a full fledged business plan. The path that results in the highest ratio of return over effort will be used for commercialization.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: https://op.europa.eu/en/web/eu-vocabularies/euroscivoc.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: https://op.europa.eu/en/web/eu-vocabularies/euroscivoc.
- medical and health sciences medical biotechnology cells technologies stem cells
- medical and health sciences clinical medicine oncology
You need to log in or register to use this function
We are sorry... an unexpected error occurred during execution.
You need to be authenticated. Your session might have expired.
Thank you for your feedback. You will soon receive an email to confirm the submission. If you have selected to be notified about the reporting status, you will also be contacted when the reporting status will change.
Programme(s)
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Topic(s)
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Call for proposal
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
ERC-2012-PoC
See other projects for this call
Funding Scheme
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Host institution
3584 CX Utrecht
Netherlands
The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.